These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 12426565)

  • 1. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.
    Diefenbach A; Tomasello E; Lucas M; Jamieson AM; Hsia JK; Vivier E; Raulet DH
    Nat Immunol; 2002 Dec; 3(12):1142-9. PubMed ID: 12426565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile signaling through NKG2D.
    Long EO
    Nat Immunol; 2002 Dec; 3(12):1119-20. PubMed ID: 12447364
    [No Abstract]   [Full Text] [Related]  

  • 5. NKG2D and Related Immunoreceptors.
    Strong RK; McFarland BJ
    Adv Protein Chem; 2004; 68():281-312. PubMed ID: 15500864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UL16 binding proteins.
    Cao W; He W
    Immunobiology; 2004; 209(3):283-90. PubMed ID: 15518340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
    Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E; Kristensson K; Ljunggren HG
    Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes.
    Upshaw JL; Leibson PJ
    Semin Immunol; 2006 Jun; 18(3):167-75. PubMed ID: 16723257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.
    Horng T; Bezbradica JS; Medzhitov R
    Nat Immunol; 2007 Dec; 8(12):1345-52. PubMed ID: 17952078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D.
    Savithri B; Khar A
    Eur J Immunol; 2006 Jan; 36(1):107-17. PubMed ID: 16323246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NKG2D receptor: sensing stressed cells.
    López-Larrea C; Suárez-Alvarez B; López-Soto A; López-Vázquez A; Gonzalez S
    Trends Mol Med; 2008 Apr; 14(4):179-89. PubMed ID: 18353724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
    Schrama D; Terheyden P; Otto K; Kämmerer U; Bröcker EB; Lühder F; Cosman D; Andersen MH; Becker JC
    Eur J Immunol; 2006 Jan; 36(1):65-72. PubMed ID: 16342232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions.
    Tomasello E; Vivier E
    Eur J Immunol; 2005 Jun; 35(6):1670-7. PubMed ID: 15884055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways.
    Coudert JD; Scarpellino L; Gros F; Vivier E; Held W
    Blood; 2008 Apr; 111(7):3571-8. PubMed ID: 18198346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways participating in activation of mouse uterine natural killer cells during pregnancy.
    Xie X; He H; Colonna M; Seya T; Takai T; Croy BA
    Biol Reprod; 2005 Sep; 73(3):510-8. PubMed ID: 15878887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the NKG2D immunoreceptor and its ligands.
    Raulet DH
    Nat Rev Immunol; 2003 Oct; 3(10):781-90. PubMed ID: 14523385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.